ANIK FY 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$114M-23.0% YoY

Gross Profit

$73M64.3% margin

Operating Income

$4M3.2% margin

Net Income

-$15M-13.1% margin

EPS (Diluted)

$-1.02

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$3M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$349M

Total Liabilities

$64M

Stockholders' Equity

$286M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$114M	$148M	-23.0%
Gross Profit	$73M	$83M	-11.7%
Operating Income	$4M	$3M	+40.3%
Net Income	-$15M	$4M	-459.4%